Arrowstreet Capital
ARRY

Arrowstreet Capital’s Array Biopharma Inc ARRY Stock Holding History

Arrowstreet Capital’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-74,219
Closed -$1.21M – 1407
2018
Q1 		$1.21M Buy
+74,219
New +$1.19M ﹤0.01% 834
2017
Q3 		– Sell
-120,500
Closed -$1.01M – 1324
2017
Q2 		$1.01M Sell
120,500
-19,800
-14% -$162K ﹤0.01% 777
2017
Q1 		$1.25M Buy
+140,300
New +$1.49M ﹤0.01% 922
2016
Q4 		– Sell
-142,294
Closed -$960K – 2812
2016
Q3 		$960K Buy
+142,294
New +$550K ﹤0.01% 1081

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Arrowstreet Capital's ARRY Position: Q2 2018 in Review

Arrowstreet Capital sold out of Array Biopharma Inc (ARRY) in Q2 2018, closing a stake of 74,219 shares — an estimated $1.21M sold.

Arrowstreet Capital first reported a position in ARRY in Q3 2016 and held it in 4 quarters. The position peaked at $1.25M in Q1 2017. 223 funds tracked by Wall St. Rank hold ARRY as of Q2 2018.

  • Arrowstreet Capital reported no remaining Array Biopharma Inc position as of Q2 2018 after selling out during the quarter.
  • Arrowstreet Capital sold 74,219 Array Biopharma Inc shares in Q2 2018, an estimated $1.21M.
  • Arrowstreet Capital first reported a position in Array Biopharma Inc in Q3 2016 and held it in 4 quarters.
  • Arrowstreet Capital's Array Biopharma Inc position peaked at $1.25M in Q1 2017.
  • 223 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2018.

Based on Arrowstreet Capital's 13F filing for Q2 2018, filed 14 Aug 2018.